Current partner codePEPTIDESDE
NCT07033104·Not applicable·INTERVENTIONAL

Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

Status

Recruiting

Phase

Not applicable

Enrollment

70

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

Interventions

Treatment arms and agents.

OTHER

us guided Transversalis fascia plane block

addition of calcitonin to pubivacaine

Timeline

From registration to results.

  1. First posted

    Jun 24, 2025

  2. Study start

    Apr 1, 2025

  3. Primary completion

    Aug 1, 2025

  4. Study completion

    Sep 1, 2025

  5. Results posted

    Not reported

  6. Registry updated

    Jun 24, 2025

Outcomes

What the study measures.

Primary outcomes

time to first rescue analgesia

Time frame · 24 hours

Secondary outcomes

Not reported in the indexed record.

Eligibility

Who can take part.

Minimum age
Not reported
Maximum age
Not reported
Sex
FEMALE
Healthy volunteers
No

Inclusion Criteria: * female pt ASA2 scheduled for cs under spinal anesthesia Exclusion Criteria: * patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

Study locations

1 registered sites.

Egypt. Showing up to 24 locations stored in the fast local snapshot.

tanta University hospital

Tanta, Gharbia Governorate, Egypt

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Calcitonin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.